Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients | Synapse
March 3, 2026Open Access
Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients
Key Points
Improvement in symptoms of dysmenorrhea and uterine bleeding was noted in patients with adenomyosis.
The analysis highlights the effectiveness of a combination of estetrol 15 mg and drospirenone 3 mg treatments.
Post hoc analysis based on a previous clinical study registered with the jRCT.
Findings may influence treatment options for women suffering from adenomyosis-related symptoms.